tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Kostas Biliouris, 113 are a BUY (80.14%), 28 are a HOLD (19.86%).
Analyst Kostas Biliouris, currently employed at OPPENHEIMER, carries an average stock price target met ratio of 33.11% that have a potential upside of 44.88% achieved within 85 days.
Kostas Biliouris’s has documented 289 price targets and ratings displayed on 23 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on ALNY, Alnylam Pharmaceuticals at 31-Jul-2026.
Analyst best performing recommendations are on BEAM (BEAM THERAPEUTICS).
The best stock recommendation documented was for BEAM (BEAM THERAPEUTICS) at 7/18/2022. The price target of $61 was fulfilled within 1 day with a profit of $2.99 (5.15%) receiving and performance score of 51.54.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 02-Mar-2020
$65
$40.5 (165.31%)
$65
26 days ago
(09-Sep-2026)
3/9 (33.33%)
$39.82 (158.14%)
154
Buy Since 23-Jul-2024
$80
$55.5 (226.53%)
$80
1 months 10 days ago
(25-Aug-2026)
0/16 (0%)
$48.97 (157.82%)
Buy Since 08-Jul-2026
$47
$22.5 (91.84%)
$47
2 months 20 days ago
(15-Jul-2026)
0/3 (0%)
$16.16 (52.40%)
Buy Since 13-Dec-2022
$68
$33.19 (95.35%)
$56
6 months 9 days ago
(26-Mar-2026)
0/3 (0%)
$44.38 (187.89%)
Hold Since 04-May-2021
$26
$-8.81 (-25.31%)
$20
7 months 10 days ago
(25-Feb-2026)
8/8 (100%)
$-3.61 (-12.19%)
22
Which stock is Kostas Biliouris most bullish on?
What Year was the first public recommendation made by Kostas Biliouris?
